Rusch VW, Nicholas A, Patterson GA, Waqar SN, et al. Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non-small cell lun J Thorac Cardiovasc Surg 2022 Oct 8. pii: S0022-5223(22)01055.
PMID: 36369159